Literature DB >> 10647795

Human papillomavirus antibody and risk of prostate cancer.

M Hisada, C S Rabkin, H D Strickler, W E Wright, R E Christianson, B J van den Berg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10647795     DOI： 10.1001/jama.283.3.340-a

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review.

Authors:  Sarah M Tiggelaar; Margaret J Lin; Raphael P Viscidi; Jia Ji; Jennifer S Smith
Journal:  J Adolesc Health       Date:  2012-02       Impact factor: 5.012

2.  Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.

Authors:  Siobhan Sutcliffe; Raphael P Viscidi; Cathee Till; Phyllis J Goodman; Ashraful M Hoque; Ann W Hsing; Ian M Thompson; Jonathan M Zenilman; Angelo M De Marzo; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

3.  Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis.

Authors:  Y Lin; Q Mao; X Zheng; K Yang; H Chen; C Zhou; L Xie
Journal:  Ir J Med Sci       Date:  2011-03-12       Impact factor: 1.568

4.  Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.

Authors:  Siobhan Sutcliffe; Edward Giovannucci; Charlotte A Gaydos; Raphael P Viscidi; Frank J Jenkins; Jonathan M Zenilman; Lisa P Jacobson; Angelo M De Marzo; Walter C Willett; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08       Impact factor: 4.254

5.  [Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance?].

Authors:  M May; R Kalisch; B Hoschke; T Juretzek; F Wagenlehner; S Brookman-Amissah; I Spivak; K-P Braun; W Bär; C Helke
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

6.  Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study.

Authors:  Jan Hrbacek; Michael Urban; Eva Hamsikova; Ruth Tachezy; Vaclav Eis; Marek Brabec; Jiri Heracek
Journal:  BMC Cancer       Date:  2011-02-03       Impact factor: 4.430

7.  Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis.

Authors:  Lin Yang; Shuanghua Xie; Xiaoshuang Feng; Yuheng Chen; Tongzhang Zheng; Min Dai; Cindy Ke Zhou; Zhibin Hu; Ni Li; Dong Hang
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

8.  Identifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach.

Authors:  Fei Yuan; You Zhou; Meng Wang; Jing Yang; Kai Wu; Changhong Lu; Xiangyin Kong; Yu-Dong Cai
Journal:  Comput Math Methods Med       Date:  2015-10-04       Impact factor: 2.238
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.